Using Addiction Comprehensive Health Enhancement Support System (ACHESS) in an Alcoholic Liver Disease Population

NCT ID: NCT03388320

Last Updated: 2019-03-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-04-24

Study Completion Date

2021-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a pilot study examining whether an evidence-based recovery support smartphone application, the Addiction Comprehensive Health Enhancement Support System (A-CHESS), can decrease alcohol recidivism in a previously unstudied group of patients with alcoholic liver disease (ALD).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A-CHESS is a smartphone application developed by the University of Wisconsin-Madison based on self-determination theory, with a previous randomized clinical trial showing that use of the app resulted in significantly fewer risky drinking days in patients leaving treatment for alcohol-use disorders. The application is downloaded to the participant's smartphone, and provides ongoing access to peer support and educational materials, monitoring of the risk of relapse, and delivery of reminders and encouragements to the patient. The application also has a survey platform to assess and reassess the participants' most recent alcohol consumption, quality of life, and experience using the application. We anticipate that use of the A-CHESS app will result in decreased drinking and improved abstinence, identifying a potential intervention to offer patients with ALD to improve their mortality, liver disease, and likelihood of liver transplant candidacy status.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Diseases, Alcoholic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Participants receiving A-CHESS

Participants will be provided access to the smartphone application A-CHESS (intervention) that will be downloaded to their phone.

Group Type EXPERIMENTAL

A-CHESS

Intervention Type DEVICE

Use of smartphone application: Addiction Comprehensive Health Enhancement Support System (A-CHESS)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A-CHESS

Use of smartphone application: Addiction Comprehensive Health Enhancement Support System (A-CHESS)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Alcoholic liver disease
* Followed or seen at New York Presbyterian Hospital / Weill Cornell Medical Center
* English speaking
* Access to a smartphone

Exclusion Criteria

* Unable to consent
* Primary language other than English
* No access to a smartphone
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Wisconsin, Madison

OTHER

Sponsor Role collaborator

New York Presbyterian Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nicole T Shen

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert S Brown, MD, MPH

Role: PRINCIPAL_INVESTIGATOR

Weill Cornell Medical College/NYPH

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center

New York, New York, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Nicole T Shen, MD

Role: CONTACT

3146095911

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nicole T Shen, MD

Role: primary

314-609-5911

Cecilia M Mero

Role: backup

(646) 962-9358

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1704018122

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mobile App in Addiction
NCT04133688 COMPLETED NA
Validation of Alcohol Level Identification Using DRIVESC
NCT07282405 ENROLLING_BY_INVITATION NA